We compared PCR results from SARS-CoV-2-positive patients tested in the community in France from 14 June to 30 July 2021. In asymptomatic individuals, Cq values were significantly higher in fully vaccinated than non-fully vaccinated individuals (effect size: 1.7; 95% CI: 1–2.3; p < 10 −6 ). In symptomatic individuals and controlling for time since symptoms, the difference vanished (p = 0.26). Infections with the Delta variant had lower Cq values at symptom onset than with Alpha (effect size: −3.32; 95% CI: −4.38 to −2.25; p < 10 −6 ).
All Keywords
【저자키워드】 SARS-CoV-2, vaccination, Delta, Breakthrough infection, 【초록키워드】 delta variant, Symptoms, PCR, Asymptomatic individuals, Community, France, Alpha, Cq value, symptom onset, 95% CI, symptomatic individuals, SARS-CoV-2-positive patients, effect size, vaccinated individual, Cq values, tested, significantly higher, SARS-CoV-2-positive patient, symptomatic individual, 【제목키워드】 Viral load, Community, Alpha variant, vaccine breakthrough infection,
【저자키워드】 SARS-CoV-2, vaccination, Delta, Breakthrough infection, 【초록키워드】 delta variant, Symptoms, PCR, Asymptomatic individuals, Community, France, Alpha, Cq value, symptom onset, 95% CI, symptomatic individuals, SARS-CoV-2-positive patients, effect size, vaccinated individual, Cq values, tested, significantly higher, SARS-CoV-2-positive patient, symptomatic individual, 【제목키워드】 Viral load, Community, Alpha variant, vaccine breakthrough infection,
우리는 2021년 6월 14일부터 7월 30일까지 프랑스 지역 사회에서 테스트한 SARS-CoV-2 양성 환자의 PCR 결과를 비교했습니다. 무증상 개인에서 Cq 값은 완전 예방접종을 받은 사람보다 완전 예방접종을 받은 사람에서 유의하게 더 높았습니다(효과 크기: 1.7 95% 신뢰구간: 1–2.3, p< 10 -6 ). 증상이 있는 개인과 증상 이후 시간에 대한 통제에서는 차이가 사라졌습니다(p= 0.26). Delta 변이체의 감염은 Alpha보다 증상 발병 시 Cq 값이 더 낮았습니다(효과 크기: -3.32; 95% CI: -4.38 ~ -2.25; p< 10 -6 ).